John Campbell

John Campbell has a diverse work experience in various roles and organizations. John is currently an Executive In Residence at Delin Ventures and a Chief Scientific Officer at adthera bio. In 2021, they founded Resolution Therapeutics where they serve as an Advisor. Prior to that, they held positions as an Honorary Professor at the University of Edinburgh and the University of Glasgow. From 2013 to 2022, they were the Director of Tissues, Cells, and Advanced Therapeutics at the Scottish National Blood Transfusion Service. Earlier in their career, they worked at Miltenyi Biotec as a Manager in the Clinical Science and Cell Analysis Group and as a Project Leader in R&D. John also served as a Lecturer in Transfusion Medicine at the University of Glasgow.

John Campbell obtained a Bachelor of Science (BSc) degree in Cell and Immunobiology from the University of Aberdeen, which they attended from 1986 to 1990. Following their undergraduate studies, they pursued further education at The University of Edinburgh, where they completed a Doctor of Philosophy (PhD) degree in Pathology/Experimental Pathology from 1991 to 1995.